financetom
Business
financetom
/
Business
/
Select Medical Holdings Insider Sold Shares Worth $1,415,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Select Medical Holdings Insider Sold Shares Worth $1,415,000, According to a Recent SEC Filing
Mar 11, 2024 2:21 PM

04:47 PM EDT, 03/11/2024 (MT Newswires) -- Robert A Ortenzio, Director, Executive Chairman, on March 08, 2024, sold 50,000 shares in Select Medical Holdings ( SEM ) for $1,415,000. Following the Form 4 filing with the SEC, Ortenzio has control over a total of 12,664,718 shares of the company, with 6,739,668 shares held directly and 5,925,050 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1320414/000141588924007517/xslF345X03/form4-03112024_080324.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eightco Launches Pilot Program for Enterprise AI Authentication; Shares Up Pre-Bell
Eightco Launches Pilot Program for Enterprise AI Authentication; Shares Up Pre-Bell
Oct 10, 2025
08:55 AM EDT, 10/10/2025 (MT Newswires) -- Eightco Holdings ( ORBS ) said Friday it launched a pilot program aimed at improving artificial intelligence authentication for enterprise clients. The company said the initiative will leverage investments, partnerships, and its Worldcoin treasury to develop a universal framework for digital identity and authentication. The program will help companies analyze single sign-on capabilities...
Crispr Says CTX460 for Alpha-1 Antitrypsin Deficiency Treatment Shows 'Durable Effects' in Preclinical Studies
Crispr Says CTX460 for Alpha-1 Antitrypsin Deficiency Treatment Shows 'Durable Effects' in Preclinical Studies
Oct 10, 2025
08:55 AM EDT, 10/10/2025 (MT Newswires) -- Crispr Therapeutics ( CRSP ) said Friday that its alpha-1 antitrypsin deficiency treatment program, called CTX460, showed specific and durable effects in preclinical studies. Data demonstrated that a single dose of CTX460 resulted in significant, dose-dependent correction of liver deoxyribonucleic acid or DNA in both rat and mouse AATD models, as well as...
Form 8.3 - American Axle & Manufacturing Holdings Inc
Form 8.3 - American Axle & Manufacturing Holdings Inc
Oct 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Arrowstreet Capital, Limited Partnership (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Operational Challenges Slow Mosaic's Phosphate Division Progress
Operational Challenges Slow Mosaic's Phosphate Division Progress
Oct 10, 2025
Mosaic Company ( MOS ) shares traded significantly lower in the premarket session on Friday after the fertilizer giant released preliminary segment volumes for the third quarter of fiscal 2025. Operational challenges within the Phosphate division were the core driver behind the decline, despite positive sequential movement in other segments. The Phosphate segment disclosed third-quarter sales volumes of $1.6 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved